Novel Therapeutic Molecular Targets for Prostate Cancer: The mTor Signaling Pathway and Epidermal Growth Factor Receptor
- 1 February 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 171 (2S), S41
- https://doi.org/10.1097/01.ju.0000108100.53239.b7
Abstract
The scientific rationale and existing evidence for the use of novel molecular targets in the chemoprevention of cancer are reviewed, with special attention to prostate cancer. A search for relevant literature on basic science and clinical trials was conducted using PubMed/MEDLINE. The emergence of molecularly targeted therapies for advanced malignancies creates an important opportunity to examine these agents for the chemoprevention of prostate cancer. Two critical targets in the proliferation and malignant transformation of normal cells, the PI3/Akt signal transduction pathway and the epidermal growth factor receptor, are currently the focus of several novel investigational therapies that are in late stage phase II and phase III studies. Research to date supports consideration of these novel molecular targets as future agents in the chemoprevention of prostate cancer.Keywords
This publication has 22 references indexed in Scilit:
- Overview of Mechanisms of Action of LycopeneExperimental Biology and Medicine, 2002
- The phosphatidylinositol 3-Kinase–AKT pathway in human cancerNature Reviews Cancer, 2002
- The Diet, Prostate Inflammation, and the Development of Prostate CancerCancer and Metastasis Reviews, 2002
- T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancerProceedings of the National Academy of Sciences, 2001
- Insulin-Like Growth Factor-Binding Protein-1 and Prostate CancerJNCI Journal of the National Cancer Institute, 1999
- Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expressionProceedings of the National Academy of Sciences, 1998
- Analysis of PTEN and the 10q23 region in primary prostate carcinomasOncogene, 1998
- Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective StudyScience, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997
- Interleukin-6: A candidate mediator of human prostate cancer morbidityUrology, 1995